Glyoxalase-I is a novel target against Bcr-Abl+ leukemic cells acquiring stem-like characteristics in a hypoxic environmentMiki Takeuchi(Shiga University of Medical Science), T Maekawa(Kyoto University Hospital)Cell Death and DifferentiationFebruary 5, 201010.1038/cdd.2010.6Cited by 38SaveCiteExport RISWatch citationsRelated PapersApoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia|Cell Death and Differentiation|2007|65AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model|Blood Cancer Journal|2011|49